Related Experiment Video

Updated: Aug 5, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

CHK2 kinase expression is down-regulated due to promoter methylation in non-small cell lung cancer

Peilin Zhang1, Jie Wang, Weiyi Gao

  • 1Department of Pathology, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV 26506-9203, USA. pzhang@hsc.wvu.edu

Molecular Cancer
|May 6, 2004
PubMed
Abstract

Insights

CHK2 kinase, a tumor suppressor, is often absent in non-small cell lung cancer (NSCLC) due to gene silencing. This CHK2 loss explains NSCLC

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • CHK2 kinase is a crucial tumor suppressor involved in DNA damage response.
  • Its absence in cells confers resistance to apoptosis, similar to non-small cell lung cancer (NSCLC).

Purpose of the Study:

  • Investigate CHK2 expression in NSCLC.
  • Elucidate the mechanism behind CHK2 down-regulation in lung cancer.
  • Determine the role of CHK2 in NSCLC resistance to DNA damage therapies.

Main Methods:

  • Analysis of CHK2 expression in NSCLC cell lines and tumor specimens.
  • Investigation of CHK2 gene promoter methylation.
  • Comparison of CHK2-deficient mice with NSCLC radioresistance.

Main Results:

  • CHK2 expression is diminished or absent in NSCLC cell lines and tumors.
  • Hypermethylation of the CHK2 gene promoter causes gene silencing in NSCLC.
  • CHK2-null mice exhibit radioresistance, mirroring NSCLC behavior.

Conclusions:

  • Down-regulation of CHK2 kinase by gene silencing and methylation is a key mechanism in NSCLC.
  • Loss of CHK2 function contributes to NSCLC resistance to DNA damage-based therapies.
  • CHK2 plays a critical role in DNA damage-induced apoptosis and cancer therapy response.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN11:50

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN

Published on: April 3, 2026

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...